The U.S. orthopedic surgical robotics market is witnessing strong momentum as hospitals, ambulatory surgical centers, and surgeons increasingly adopt robotic-assisted technologies to improve precision, efficiency, and patient outcomes.
According to BIS Research, the U.S. orthopedic surgical robotics market is projected to grow from $531.1 million in 2020 to $2,046.6 million by 2031, registering a CAGR of 12.3% during 2021-2031. The market expansion is being driven by the rising burden of orthopedic disorders, growing procedure volumes, and continuous advancements in robotic-assisted surgical technologies.
Explore Surgical Procedure volume database
One of the primary factors accelerating the growth of the U.S. orthopedic surgical robotics market is the increasing volume of knee and hip replacement procedures. Aging populations, obesity, sports injuries, and osteoarthritis are significantly increasing demand for orthopedic interventions across the U.S.
Robotic-assisted systems are widely used in procedures such as total knee arthroplasty (TKA), partial knee arthroplasty (PKA), and total hip arthroplasty (THA). These robotic platforms help surgeons improve implant positioning, surgical planning, and procedural accuracy while reducing variability during surgery.
According to BIS Research analysis, more than 1,500 orthopedic surgical robotic systems had been installed in the U.S. by 2020, supporting nearly 123.5 thousand robotic-assisted orthopedic procedures annually. By 2031, the total orthopedic robotic procedure volume in the U.S. is projected to reach 961.5 thousand procedures, growing at a CAGR of 18.5%.
Knee and hip procedures continue to represent key application areas for orthopedic surgical robotics in the U.S. market. Growing demand for minimally invasive orthopedic procedures, improved implant alignment, and greater surgical precision is expected to support continued adoption across these procedure categories.
Get tailored procedure volume intelligence for orthopedic robotics & other specialties -Request a Quote
.png)
Technological innovation remains one of the strongest growth drivers in the orthopedic surgical robotics market. Advanced robotic platforms now combine imaging technologies, AI-assisted surgical planning, real-time navigation, and data-driven analytics to improve procedural outcomes and surgical efficiency.
Leading companies including Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew plc, Corin Group, and THINK Surgical, Inc. continue to expand their robotic portfolios and strengthen their market presence.
Stryker’s Mako System, Zimmer Biomet’s ROSA Knee System, and Smith & Nephew’s Cori System are among the most widely recognized robotic platforms in the market. These systems are helping surgeons perform more personalized and minimally invasive procedures with greater consistency and precision.
The integration of robotic platforms with digital operating rooms and smart surgical ecosystems is also enhancing workflow efficiency, pre-operative planning, and patient-specific treatment strategies.
The growing emphasis on value-based healthcare and patient-centric care is accelerating the adoption of orthopedic surgical robotics in the U.S. Robotic-assisted orthopedic procedures offer several clinical advantages, including:
• Greater surgical precision
• Improved implant alignment
• Reduced soft tissue damage
• Faster patient recovery
• Lower revision surgery rates
• Reduced hospital stay durations
As patient awareness regarding robotic-assisted surgery increases, healthcare providers are investing more aggressively in advanced orthopedic robotics platforms to remain competitive and improve surgical outcomes.
See how BIS Research’s Surgical Procedure Volume Database supports market sizing, forecasting, and growth planning- Schedule a Demo
Despite the strong growth outlook, several challenges continue to impact broader adoption of orthopedic surgical robotics across healthcare facilities.
1. High Initial Investment Costs: Orthopedic robotic systems involve substantial capital expenditure related to hardware, software integration, maintenance, and surgeon training. Smaller hospitals and outpatient centers often face budget limitations that can delay adoption.
2. Training and Workflow Integration: Robotic-assisted orthopedic surgery requires dedicated surgeon training and workflow optimization. The learning curve associated with robotic systems can temporarily affect operating room efficiency during the transition phase.
3. Reimbursement and Cost Management Concerns: Healthcare providers continue to evaluate the financial viability of robotic programs, particularly regarding reimbursement structures and long-term return on investment. Efficient utilization remains critical for maximizing profitability.
The U.S. orthopedic surgical robotics market remains highly competitive, with companies focusing on acquisitions, partnerships, AI integration, and product innovation to strengthen their positions.
Stryker Corporation currently maintains a dominant market share position, accounting for approximately 68.3% of the market in 2020. Zimmer Biomet Holdings and Smith & Nephew are also rapidly expanding their robotic surgery capabilities and installed base across hospitals and surgical centers.
Future innovations expected to shape the market include:
• AI-driven surgical planning
• Cloud-connected robotic systems
• Augmented reality-assisted surgery
• Smart implant integration
• Machine learning-enabled analytics
• Personalized orthopedic treatment solutions
The increasing shift toward outpatient orthopedic procedures and ambulatory surgical centers is also expected to create strong opportunities for compact and cost-efficient robotic platforms.
The future of the U.S. orthopedic surgical robotics market remains highly promising as healthcare systems continue to prioritize precision surgery, efficiency, and improved patient outcomes. Rising orthopedic procedure volumes, rapid technological advancements, and growing surgeon acceptance are expected to sustain long-term market growth.
As robotic-assisted orthopedic surgery becomes more mainstream, innovation and competition among leading companies will continue to drive market expansion across the U.S. healthcare ecosystem.
For deeper market intelligence and procedure-level insights, explore BIS Research’s - Surgical Procedure Volume Database
